Logo

BD s Allegedly Illegal Iraqi Shipments, FDA Rule Violations Tops Most-Read GenomeWeb News Stories Last Week

Dec 05, 2005

NEW YORK, Dec. 5 (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Dec. 2.

 

1. BD Attempted Illegal Shipments to Iraq and Violated FDA Rules, Wrongful Termination Suit Alleges (from Dec. 1)

2. US Department of Homeland Security Awards US Genomics $16.2M (from Nov. 30)

3. LabCorp to Sell Roche's AmpliChip CYP450 Assay (from Nov. 28)

4. Agilent Buys Molecular Imaging in Bid to Expand Nanotech Imaging Business (from Nov. 29)

5. Invitrogen Wins One Patent Battle Against Clontech on Appeal; Status of Two Remaining Patents Unclear (from Dec. 1)

Breaking News
The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.